Parallel Advisors’s Cartesian Therapeutics RNAC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $31 | Buy |
103
+100
| +3,333% | +$30 | ﹤0.01% | 3477 |
|
|
2025
Q1 | $40 | Hold |
3
| – | – | ﹤0.01% | 3457 |
|
|
2024
Q4 | $54 | Hold |
3
| – | – | ﹤0.01% | 3453 |
|
|
2024
Q3 | $48 | Hold |
3
| – | – | ﹤0.01% | 3346 |
|
|
2024
Q2 | $81 | Hold |
3
| – | – | ﹤0.01% | 3241 |
|
|
2024
Q1 | $65 | Sell |
3
-4
| -57% | -$87 | ﹤0.01% | 3216 |
|
|
2023
Q4 | $69 | Buy |
7
+4
| +133% | +$39 | ﹤0.01% | 3238 |
|
|
2023
Q3 | $106 | Hold |
3
| – | – | ﹤0.01% | 3271 |
|
|
2023
Q2 | $112 | Hold |
3
| – | – | ﹤0.01% | 3275 |
|
|
2023
Q1 | $139 | Hold |
3
| – | – | ﹤0.01% | 3307 |
|
|
2022
Q4 | $113 | Hold |
3
| – | – | ﹤0.01% | 3248 |
|
|
2022
Q3 | $0 | Hold |
3
| – | – | ﹤0.01% | 3435 |
|
|
2022
Q2 | $0 | Hold |
3
| – | – | ﹤0.01% | 3291 |
|
|
2022
Q1 | $0 | Hold |
3
| – | – | ﹤0.01% | 3230 |
|
|
2021
Q4 | $0 | Hold |
3
| – | – | ﹤0.01% | 3268 |
|
|
2021
Q3 | $0 | Hold |
3
| – | – | ﹤0.01% | 3208 |
|
|
2021
Q2 | $0 | Hold |
3
| – | – | ﹤0.01% | 3026 |
|
|
2021
Q1 | $0 | Sell |
3
-4
| -57% | – | ﹤0.01% | 2872 |
|
|
2020
Q4 | $1K | Buy |
+7
| New | +$1K | ﹤0.01% | 2454 |
|